论文部分内容阅读
[目的]观察脑心通联合尼莫地平治疗气滞血瘀眩晕疗效。[方法]使用随机平行对照方法,将60例住院患者按病志号抽签方法简单随机分为两组。对照组30例尼莫地平,20mg/次,3次/d,口服。治疗组30例脑心通,4粒/次,3次/d,口服;尼莫地平治疗同对照组。连续治疗1个月为1疗程。观测临床症状、神经功能缺损评分、全血高切黏度、全血低切浓度、生活质量评分、不良反应。治疗1疗程(1个月),判定疗效。[结果]治疗组显效15例,有效13例,无效2例,总有效率93.33%;对照组显效10例,有效8例,无效12例,总有效率90.00%;治疗组疗效优于对照组(P<0.05)。全血高切黏度、全血低切浓度两组均有改善(P<0.01),治疗组改善优于对照组(P<0.01)。神经功能缺损评分两组均有改善(P<0.01),治疗组改善优于对照组(P<0.01)。生活质量评分两组均有改善(P<0.01),治疗组改善优于对照组(P<0.01)。[结论]脑心通联合尼莫地平治疗气滞血瘀眩晕,疗效满意,无严重不良反应,值得推广。
[Objective] To observe the curative effect of Naoxintong combined with nimodipine in treating blood stasis and dizziness. [Methods] Using randomized parallel control method, 60 inpatients were randomly divided into two groups randomly according to the method of lot drawing. Control group 30 cases of nimodipine, 20mg / time, 3 times / d, orally. The treatment group, 30 cases of Naoxintong, 4 tablets / time, 3 times / d, oral; nimodipine treatment with the control group. Continuous treatment for 1 month for a course of treatment. Observation of clinical symptoms, neurological deficit score, whole blood high shear viscosity, whole blood low-cut concentration, quality of life score, adverse reactions. Treatment 1 course of treatment (1 month), determine the efficacy. [Results] In the treatment group, 15 cases were markedly effective, 13 cases were effective, 2 cases were ineffective, and the total effective rate was 93.33%. In the control group, 10 cases were markedly effective, 8 cases effective, 12 ineffective, and the total effective rate was 90.00% (P <0.05). High blood viscosity of whole blood and low blood cut of whole blood were improved in both groups (P <0.01). The treatment group improved better than the control group (P <0.01). Neurological deficit scores were improved in both groups (P <0.01), and the treatment group improved better than the control group (P <0.01). Quality of life scores were improved in both groups (P <0.01), and the treatment group improved better than the control group (P <0.01). [Conclusion] Naoxintong combined with nimodipine is effective in treating Qi stagnation and blood stasis, and it has no serious side effects and is worth popularizing.